Radiopharmaceuticals for Sentinel Lymph Node Detection - Status and Trends

Other author International Atomic Energy Agency.
Format Electronic
Publication InfoLanham : International Atomic Energy Agency Lanham : Rowman & Littlefield Publishers, Incorporated [Distributor]
Description162 p.
Supplemental ContentFull text available from Ebook Central - Academic Complete

Summary Annotation This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspects of this diagnostic methodology, including the production of nanocolloidal particles, their biological mechanism of action and relevant clinical applications. It also illustrates the recent developments in the field fuelled by the introduction of molecular imaging agents for SLND and of multimodality optical and radioactive agents. Included in the results presented in this book, are those on the novel generation of SLND radiopharmaceuticals obtained through an IAEA Coordinated Research Project.
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
ISBN9789201097149
ISBN920109714X (Trade Paper) Active Record
Standard identifier# 9789201097149
Stock number00109194

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available